+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Injectable Drug Delivery Technology Market for Therapeutics - Segmented by Type, Application, Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4602361
  • Report
  • April 2018
  • Region: Global
  • 112 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now


  • Baxter International
  • Becton Dickinson
  • Eli Lily & Company
  • Gerresheimer AG
  • Pfizer
  • Schott AG
  • MORE
The global injectable drug delivery technology market for therapeutics is expected to witness a CAGR of 10.67%, during the forecast period. North America is estimated to dominate the global injectable drug delivery market in 2017 due to the rising incidences of chronic diseases and presence of major players in this region.

Increasing Prevalence of Chronic Diseases to Boost the Market

Some of the most common chronic diseases include, heart disease, stroke, type 2 diabetes, obesity, cancer, and arthritis. According to Centers for Disease Control and Prevention (CDC), in United States seven of the top 10 causes of death in 2014 were chronic diseases. Cancer and heart diseases together accounted for an approximate of 46 percent of all deaths. It has also reported that about half of the adults in United States had one or more chronic conditions and one if four had more than two chronic conditions. Moreover, this numbers are expected to increase in the next 10 years. Since, the adoption rate of injectable drug delivery devices is high among the population suffering from diseases, like diabetes and heart related disorders, the increasing prevalence of chronic diseases is expected to contribute for the growth of injectable drug delivery technology market in the forecast period.
The convenience in handling syringes and the automation of dispensing the drug in exact proportions is also contributing to the growth of the market.

Injuries and Infections Caused by Needles

Injuries and infections due to needles are acting as a major restraint for the global injectable drug delivery technology market. According to World Health Organization (WHO), globally there were more than 2 million needlestick injuries per year. Another study estimated these numbers often reach more than 3.5 million annually. The European Biosafety Network estimated that in 2007, there were more than 1 million needlestick injuries annually in Europe alone. WHO has estimated that with these numbers are expected to increase by atleast 20% in the next 5 years. Moreover, there has been an increment in the infections caused by needles over the past few years. Therefore, with the increasing injuries and the infections caused by needles, there is reluctance among the population to use the injections, which is hampering the growth of injectable drug delivery technology market, globally.
Growing use of alternative drug delivery methods along with safety concerns associated with the use of injections is also restraining the market.

North America is expected to hold the Largest Share of the Market

Geographically the injectable drug delivery technology market is been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America holds the major share of approximately more than 42 percent in 2017 and is expected to grow in the forecast period due to factors, such as rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in that region. Europe has holds the second largest position in the market followed by APAC region.

Key Developments in the Market
  • April 2017: BD (Becton, Dickinson and Company) and C. R. Bard, Inc. has entered into a definitive agreement

Reasons to Purchase this Report
  • Current and future injectable drug delivery technology market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identifying the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report

This report can be customized to meet your requirements. Please connect with our Customer Service team, who will ensure you get a report that suits your needs
This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5


  • Baxter International
  • Becton Dickinson
  • Eli Lily & Company
  • Gerresheimer AG
  • Pfizer
  • Schott AG
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Prevalence of Chronic Diseases
6.1.2 Benefits and Convenience with the Use of Injections
6.2 Market Restraints
6.2.1 Injuries and Infections Caused by Needles
6.2.2 Growing Use of Alternative Delivery Methods
6.2.3 Safety Concerns
6.3 Opportunities
6.4 Key challenges

7. Market segmentation
7.1 By Type
7.1.1 Devices Self-Injection Devices Conventional Injection Devices
7.1.2 Formulation Conventional Drug Delivery Novel Drug Delivery Others
7.2 By Application
7.2.1 Cardiovascular Disease
7.2.2 Diabetes
7.2.3 Regenerative Medicine
7.2.4 Oncology
7.2.5 Autoimmune Disorders
7.2.6 Hepatitis B
7.2.7 Others
7.3 By Geography
7.3.1 North America United states Canada Mexico
7.3.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
7.3.3 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest of Asia-Pacific
7.3.4 Middle East & Africa GCC South Africa Rest of the Middle East & Africa
7.3.5 South America Brazil Argentina Rest of South America

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations and Partnerships
8.3 New Products Launches

9. Key Players
9.1 Becton Dickinson
9.2 Baxter International
9.3 Pfizer
9.4 Gerresheimer AG
9.5 Terumo Corporation
9.6 Eli Lily & Company
9.7 Schott AG
9.8 Others

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Becton Dickinson
  • Baxter International
  • Pfizer
  • Gerresheimer AG
  • Terumo Corporation
  • Eli Lily & Company
  • Schott AG
Note: Product cover images may vary from those shown
5 of 5